Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy na ïve patients

ConclusionsFABP-4 is an independent predictor for both the diagnosis and high-grade Gleason score at PNB. This novel biomarker might have a promising role in optimizing PNB outcomes.

Source: International Urology and Nephrology - March 11, 2020 Category: Urology & Nephrology Source Type: research